Cite Filings / MLTX / 0001628280-23-008604

Feed Companies Filings Check

Sign in

POS AM

Post-effective Amendment for Registration Statement

MoonLake Immunotherapeutics Filed 2023-03-20 Acc 0001628280-23-008604

Documents 1

POS AM Post-effective Amendment for Registration Statement , mnlk-20221231.htm

Around this filing

2023-05-01 POS AM Post-effective Amendment for Registration Statement
2023-03-27 EFFECT Notice of Effectiveness
2023-03-22 4 10% owner bought 827,100 shares at an average $20.28 ($16,774,846)
2023-03-20 10-K Annual Report
2023-03-20 8-K Results of operations
2023-03-20 POS AM Post-effective Amendment for Registration Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading mnlk-20221231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…